Laurion Capital Management’s Precision BioSciences DTIL Stock Holding History

Laurion Capital Management’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-442	Closed	-$15.8K	–	460
2022 Q4	$15.8K	Hold	442	–	–	﹤0.01%	396
2022 Q3	$17K	Buy	+442	New	+$21K	﹤0.01%	462
2022 Q2	–	Sell	-4,484	Closed	-$414K	–	540
2022 Q1	$414K	Sell	4,484 -442	-9%	-$60.1K	0.01%	393
2021 Q4	$1.09M	Hold	4,926	–	–	0.01%	340
2021 Q3	$1.71M	Hold	4,926	–	–	0.01%	452
2021 Q2	$1.85M	Sell	4,926 -2,641	-35%	-$793K	0.01%	375
2021 Q1	$2.35M	Hold	7,567	–	–	0.01%	408
2020 Q4	$1.89M	Hold	7,567	–	–	0.01%	346
2020 Q3	$1.4M	Hold	7,567	–	–	0.02%	359
2020 Q2	$1.89M	Hold	7,567	–	–	0.02%	331
2020 Q1	$1.37M	Sell	7,567 -9,692	-56%	-$2.54M	0.01%	418
2019 Q4	$7.19M	Hold	17,259	–	–	0.06%	265
2019 Q3	$4.34M	Hold	17,259	–	–	0.03%	367
2019 Q2	$6.86M	Hold	17,259	–	–	0.07%	233
2019 Q1	$9.29M	Buy	+17,259	New	+$9.16M	0.12%	129

Other funds holding DTIL

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Laurion Capital Management's DTIL Position: Q1 2023 in Review

Laurion Capital Management sold out of Precision BioSciences (DTIL) in Q1 2023, closing a stake of 442 shares — an estimated $15.8K sold.

Laurion Capital Management first reported a position in DTIL in Q1 2019 and held it in 15 quarters. The position peaked at $9.29M in Q1 2019. 86 funds tracked by Wall St. Rank hold DTIL as of Q1 2023.

Laurion Capital Management reported no remaining Precision BioSciences position as of Q1 2023 after selling out during the quarter.
Laurion Capital Management sold 442 Precision BioSciences shares in Q1 2023, an estimated $15.8K.
Laurion Capital Management first reported a position in Precision BioSciences in Q1 2019 and held it in 15 quarters.
Laurion Capital Management's Precision BioSciences position peaked at $9.29M in Q1 2019.
86 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2023.

Based on Laurion Capital Management's 13F filing for Q1 2023, filed 15 May 2023.